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This study revealed that CWR22Rv-1 cells overexpressing d-catenin display bigger tumor formation
and higher angiogenic potentials than their matched control cells in the CAM assay. In addition, d-
catenin overexpression in CWR22Rv-1 cells results in increased hypoxia-inducible factor 1-alpha
(HIF-1a) and vascular endothelial growth factor (VEGF) expression. Furthermore, d-catenin overex-
pression was found to enhance nuclear distribution of both b-catenin and HIF-1a in hypoxic condi-
tion, which is diminished by knockdown of d-catenin. Our current study adds novel evidence
regarding contribution of d-catenin to the progression of prostate cancer.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Angiogenesis, the formation of new capillaries from pre-exist-
ing blood vessels through activation, proliferation, and migration
of endothelial cells, is a normal process in growth and develop-
ment, as well as in wound healing [1]. However, this is also a fun-
damental step in the transition of a tumor from a dormant state to
a malignant state [2]. It is well known that oxygen and nutrients
are needed to maintain a tumor’s vital activity, and without a blood
supply, a tumor cannot exceed a diameter of 2 mm due to hypoxia,
resulting in consequent death of tumor cells. Therefore, scientists
have been working on developing drugs targeting the key mole-
cules involved in the process of angiogenesis [3,4].
d-Catenin is a member of the p120-catenin subfamily of arma-
dillo protein and was ﬁrst identiﬁed through its interaction with
presenilin-1 [5]. d-Catenin is well known to be abundantly ex-
pressed in the brain being implicated in the regulation of dendro-genesis and cognitive function. Recently, overexpression of d-
catenin has been found in a variety of cancer tissues including
prostate, ovarian, and lung tumors [6–13]. Based on the studies
on upregulation of d-catenin in prostate cancer [6,7], d-catenin
has been considered as one of the diagnostic markers for prostate
cancer [7,8], making the function of d-catenin in prostate cancer
signiﬁcant. Despite its close correlation with the disease proven
by accumulated evidence, it remains unclear how d-catenin con-
tributes to prostate cancer.
Recently, d-catenin has also been observed to be expressed in
vascular endothelium, being involved in endothelial cell motility
and vascular assembly in pathological angiogenesis [14]. This led
us to ask whether d-catenin expressed in prostate tumors is
responsible for angiogenesis as was observed in vascular
endothelium.
In the present study, we tested the hypothesis that d-catenin
promotes angiogenesis in prostate cancer cells. We demonstrated,
for the ﬁrst time, that d-catenin overexpressed in CWR22Rv-1
prostate cancer cells promoted angiogenesis through increasing
HIF-1a expression and augmenting nuclear distribution of b-cate-
nin to enhance the transcriptional ability of HIF-1a under hypoxic
condition, in turn, to increase the production of VEGF.
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2.1. Materials
The anti-VEGF and anti-HIF-1a antibodies were obtained from
Santa Cruz biotechnology. The anti-d-catenin antibody was pur-
chased from BD bioscience. The anti-GFP and anti-b-catenin anti-
bodies were supplied from Sigma–Aldrich. The anti-b-actin
antibody was purchased from Calbiochem. The anti-d-catenin siR-
NA and control-siRNA were obtained from Sigma–Aldrich. The
anti-b-catenin siRNA and control-siRNA were purchased from Cell
Signaling Technology. The anti-a-tubulin antibody was from Sig-
ma–Aldrich while the anti-lamin B was from Santa Cruz
biotechnology.
2.2. Cell culture and generation of hypoxic condition
Rv/C or Rv/d cells were cultured in RPMI media supplemented
with 10% FBS, 1% penicillin and G418 (Sigma) 125 lg/ml.
Hypoxic condition was generated by incubating cells with
300 lM CoCl2. The duration of hypoxic incubation is designed to
be 6, 12, 16, 18 and 24 h, according to the purposes of experiments.
2.3. CAM assay
CAM assay was conducted according to published methods
[15,16]. Fertilized chicken eggs were incubated at 37 C under con-
ditions of constant humidity. The false air sac technique was per-
formed to cut a window on the side of 10-day-old, post-
fertilization chick eggs exposing the CAM. Both Rv/C and Rv/d cells
were plated on the exposed CAM, and the windows were sealed
with transparent tape. VEGF (20 ng/ml) was explored as a standard
pro-angiogenic agent, and PBS and matrigel were used as negative
controls. The CAMs were examined at 72 h intervals post-inocula-
tion using a SV6 stereomicroscope (Car Zeiss, Hamburg, Germany)
at 50 magniﬁcation. Digital images of CAM sections were col-
lected using a 3-charged coupled color video camera system (Tos-
hiba, Tokyo, Japan). The images were analyzed using Image-Pro
software (Media Cybernetics, Linton, England). The number of ves-
sel branch points contained in a circular region was counted.
2.4. Immunoblot analysis
Cellular proteins were harvested from Rv/C and Rv/d cells using
RIPA lysis buffer (1% TritonX-100, 0.5% deoxycholate, 0.1% SDS,
150 mM NaCl, 50 mM Tris–HCl, 2 mM EDTA, 1 mM sodium ortho-
vanadate, 10 lg/ml leupeptin, 5 lg/ml aprotinin, 1 mM phenyl-
methylsulfonyl ﬂuoride, proteinase inhibitor cocktail). Protein
lysates were quantiﬁed by BCA assay kit (Pierce, Rockford, IL)
and transferred to a polyvinylidene diﬂuoride (PVDF) membrane
(Millipore, Billerica, MA) which was subsequently probed with
antibodies. Bound antibodies were visualized with horse-radish
peroxidase-conjugated secondary antibodies followed by visuali-
zation with enhanced chemiluminescence (ECL) immunobloting
detection reagents (Millipore, Billerica, MA).
2.5. VEGF enzyme-linked immunosorbent assay (ELISA)
A commercial ELISA kit (Invitrogen)was explored to detect VEGF
concentration in culture media, according to the manufacturer’s
protocol. Cells were maintained in 6-well culture plates and incu-
bated in serum-free RPMI media for 24 h. The media were then col-
lected to perform the ELISA experiment. VEGF concentrations were
determined by measuring absorbance at 450 nm, and VEGF values
were normalized to the total protein concentration in each well.2.6. Cell fractionation
To separate the nuclear extract from the cytoplasm and mem-
brane, the Nuclear and Cytoplasmic Extraction Reagents (Thermo)
was used, according to the manufacturer’s protocol. Brieﬂy, cells
were plated in 100 mm2 dishes. Next, cells were harvested with
the commercial reagents. After obtaining the extracts from differ-
ent parts of cells, western blot was performed. The anti-a-tubulin
antibody was used as a cytoplasm marker while the anti-Lamin B
antibody was used as a nucleus marker.
2.7. Generation of stable cell lines and xenograft-tumours
As previously described [17], to generate stable Rv/d cell line,
full length d-catenin with pEGFP fusion was transfected using Fu-
GENE6 into CWR22Rv-1 cells, pEGFP was transfected as a vector
control to produce Rv/C cell line. Firstly, these transfected cells
were selected in G418 containing medium. Then the survived cells
were further selected by GFP-based cell sorting using a FACS Van-
tage. The stable cell lines were maintained in RPMI 1640 medium
containing G418.
To generate the in vivo human cancer xenograft model using
Chick Chorioallantoic Membrane (CAM). For tumor implantation,
cancer cells grown in monolayers were trypsinized, washed, and
re-suspended in serum-free DMEM medium at 4 C. The cells were
then mixed with 50% (v/v) growth factor reduced Matrigel (GFR
Matrigel, BD Biosciences, San Jose, CA, USA). Thirty microliters con-
taining cancer cell suspension at a density of about 1.5  106 cells/
CAM was then loaded directly onto CAMs. After incubation for
5 days, CAM tissues around areas of implantation were resected
from the embryos and photographed under a light microscope (Lei-
ca, Germany). The tumors were then carefully removed without
other adjacent CAM tissue and weighed. The regions occupied by
tumor cells and the numbers of vessels were quantiﬁed on the pre-
pared individual histological tumor samples using a digital image
analyzer (DMI-300, DMI, Korea).
3. Results
3.1. CWR22Rv-1 prostate cancer cells overexpressing d-catenin
showed increased angiogenic potential in CAM assay
To evaluate the potential role of d-catenin in angiogenesis, two
stable CWR22Rv-1 cell lines, designated as Rv/C and Rv/d, that
over-expressed either GFP or mouse GFP-d-catenin respectively,
were explored in the CAM assay. CAMs bearing Rv/d cell masses
showed numerous blood vessels radiating from the cell mass
(Fig. 1A and B) at higher intensity than the VEGF treated control
samples. The Rv/C cell masses also induced the formation of blood
vessel branches, but the number of branches was obviously lower
than the number of branches of the Rv/d induced (Fig. 1A and B).
Also, Rv/d cells were able to form bigger tumors than Rv/C cells
in the CAM assay (Fig. 1C and D), which is in agreement with the
high angiogenic potential of Rv/d cells. The immunohistochemical
staining was performed in the xenograft tumor tissues with anti-
mouse CD34 antibody to evaluate microvessels in these tumors.
The number of microvessels in the tumors induced by Rv/d cells
was much higher than those in the tumors induced by Rv/C cells
(date not shown).
3.2. d-Catenin affected VEGF protein expression and secretion in
CWR22Rv-1 cells
The observations in the CAM assay led us to question whether
d-catenin affected VEGF expression and secretion due to the
Fig. 1. The increased angiogenic potential in d-catenin over-expressed prostate cancer cells. (A) Representative pictures of angiogenesis induced by both Rv/d and Rv/C cells.
The control CAMs of a 10-day-old chick embryo were exposed to PBS, Matrigel or VEGF (20 ng/ml). The test CAMs were implanted with Rv/d and Rv/C cells (2  106 cells/
CAM). (B) The quantitation of new blood vessel branches formed from pre-existing blood vessels was performed 3 days after cancer cell implantation. Data represent
mean ± S.D. (n = 8–10) (Signiﬁcant compared to the PBS-treated CAM group, ⁄P < 0.05; signiﬁcant compared to the Rv/C cells implanted group, #P < 0.05). (C) Representative
pictures of tumor masses originated from Rv/d and Rv/C cells in CAMs. (D) The weight of the tumors are measured (signiﬁcant compared to the tumors that originated from
Rv/C cells, ⁄P < 0.05).
Fig. 2. VEGF production and HIF-1a expression were enhanced by d-catenin overexpression in CWR22Rv-1 cells. (A) The VEGF protein expression in total cell lysate was
measured by immunoblot analysis. Hypoxic condition was induced by incubating cells with 300 lM CoCl2 for 16 h. (B) Rv/d and Rv/C cells were incubated in serum-free
media for 24 h and the culture media (50 ll) were collected to perform the VEGF ELISA experiment. Data represent mean ± S.D. (n = 3) (signiﬁcant compared to the control Rv/
C cells, ⁄P < 0.05). (C) VEGF expression was affected by hypoxic condition. Rv/d and Rv/C cells were cultured in 6 wells treated with 300 lM CoCl2 1 day after splitting and
were harvested after being treated with CoCl2 for 0, 6, 12, 18, 24 h. Immunoblot was performed to compare VEGF and HIF-1a expression in two cell lines at different time
points. (D) The HIF-1a protein expression under normoxia and hypoxia was measured in the cell lysate obtained from both Rv/d and Rv/C cells. Hypoxic condition was
induced by treating cells with CoCl2 for 16 h.
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analysis and ELISA were performed to compare the VEGF protein
production between Rv/d and Rv/C cells. We observed that VEGF
protein expression in total Rv/d cell lysate was higher than those
in control Rv/C cells (Fig. 2A), and the secreted VEGF protein con-
centration in Rv/d cells’ culture media was also higher than those
in Rv/C cells’ (Fig. 2B). Since VEGF is a secreted protein, VEGF pro-
tein expression in total cell lysates was checked at different time
points under hypoxia treatment. Interestingly, under hypoxic con-
dition, VEGF expression reached the highest point much faster in
Rv/d cells (6 h) than Rv/C cells (18 h) (Fig. 2C), indicating that VEGF
can be activated faster in the presence of d-catenin. In other words,
d-catenin overexpressed in Rv/d cells can respond to the hypoxia
stimulus faster than Rv/C cells by generating VEGF to induce angi-
ogenesis. Due to the fact that HIF-1a is a key transcription factor
for activating VEGF gene expression, we further compared the
HIF-1a protein expression between Rv/d and Rv/C cells. As ex-
pected, Rv/d cells expressed more HIF-1a proteins than Rv/C cells
both in normoxic and hypoxic conditions (Fig. 2D), suggesting that
d-catenin affects VEGF expression through stabilizing HIF-1a.
To conﬁrm the ability of d-catenin in increasing VEGF protein
expression, a speciﬁc siRNA against d-catenin was introduced into
Rv/d cells to knockdown d-catenin protein expression (Fig. 3A).
Comparing with the control siRNA transfection, in the Rv/d cells
transfected with speciﬁc siRNA, VEGF protein expression was
slightly decreased in some way (Fig. 3A) and the time to reach
the highest point of VEGF expression under the hypoxic stimulusFig. 3. The decrease of VEGF production and HIF-1a expression resulted from knockd
knockdown d-catenin protein expression. Control-siRNA did not affect d-catenin expres
protein expression in total cell lysate was monitored by immunoblot analysis. Cells were
Rv/d cells transfected with both control-siRNA and speciﬁc d-catenin-siRNA were incuba
the VEGF ELISA experiment. (C) Rv/d cells transfected with both control-siRNA and spec
siRNAs being transfected into cells for 48 h and were harvested after being treated with C
expression between two groups at different time points. (D) The HIF-1a protein express
control-siRNA and speciﬁc d-catenin-siRNA.was delayed (Fig. 3C). Moreover, VEGF secretion in the medium
was decreased (Fig. 3B). HIF-1a protein expression also showed
the same pattern (Fig. 3D), indicating that d-catenin promotes
VEGF protein expression through affecting HIF-1a.
3.3. d-Catenin mediated wnt/b-catenin signaling pathway to activate
HIF-1a/VEGF pathway
We previously reported that Rv/d cells expressed dramatically
more b-catenin than Rv/C cells. We also found that d-catenin was
able to promote E-cadherin processing which increased nuclear
distribution of b-catenin, and subsequently activated target genes
expression [18]. A previous study demonstrated that b-catenin
could switch its binding from TCFs/LEF1 to HIF-1a under hypoxic
condition thereby enhancing HIF-1a mediated transcription [19].
These previous ﬁndings led us to question whether d-catenin has
an inﬂuence in VEGF expression through HIF-1a by mediating b-
catenin distribution. We ﬁrst conﬁrmed that Rv/d cells expressed
signiﬁcantly more b-catenin than that in Rv/C cells in both norm-
oxic and hypoxic conditions (Fig. 4B). We also checked E-cadherin
processing in both cell lines under normoxic and hypoxic condi-
tions. In accordance with our previous study, Rv/d cells showed
more serious E-cadherin processing compared with Rv/C cells
(Fig. 4A). Interestingly, hypoxic condition signiﬁcantly increased
the level of processed E-cadherin in Rv/d cells by some means.
We further conﬁrmed that nuclear localized b-catenin protein
expression was higher in Rv/d cells than that in Rv/C cells underown of d-catenin. (A) Speciﬁc d-catenin-siRNA was introduced into Rv/d cells to
sion while the speciﬁc siRNA signiﬁcantly reduced d-catenin expression. The VEGF
harvested after transfecting control-siRNA and speciﬁc d-catenin-siRNA for 48 h. (B)
ted with serum-free media for 24 h and the media (50 ll) was collected to perform
iﬁc d-catenin-siRNA were cultured in 6 wells and treated with 300 lM CoCl2 after
oCl2 for 0, 6, 12, 18, 24 h. Immunoblot was performed to compare VEGF and HIF-1a
ion under normoxia and hypoxia was monitored in Rv/d cells transfected with both
Fig. 4. The enhanced nuclear distribution of HIF-1a and b-catenin in d-catenin overexpressed CWR22Rv-1 cells. (A) E-cadherin processing in both Rv/d and Rv/C cells under
normoxia and hypoxia. Plasma membrane E-cadherin was detected by biotin-labeling puriﬁcation using sulfo-NHS-SS-biotin. Puriﬁed membrane E-cadherin was probed
using E-cadherin antibody purchased from BD Biosciences. (B) b-Catenin protein expression in cell lysates of both Rv/d and Rv/C cells under normoxia and hypoxia. (C)
Nuclear and cytoplasmic fractionation were performed in both Rv/d and Rv/C cells under normoxia and hypoxia. Both b-catenin and HIF-1a protein expression were
measured by immunoblot. a-Tubulin and Lamin B was used as cytoplamic and nuclear markers, respectively. (n = 3) (signiﬁcant compared to HIF-1a expression in Rv/C cells
under hypoxia, ⁄P < 0.05; signiﬁcant compared to b-catenin expression in Rv/C cells under normoxia, ⁄P < 0.05; signiﬁcant compared to b-catenin expression in Rv/C cells
under hypoxia, ⁄⁄P < 0.01). (D) Nuclear and cytoplasmic fractionation were performed in Rv/d that were transfected with either the control-siRNA or speciﬁc d-catenin-siRNA
under both normoxia and hypoxia. Both b-catenin and HIF-1a protein expression were measured by immunoblot. a-Tubulin and Lamin B antibodies were used as cytoplamic
and nuclear markers, respectively. (n = 3) (signiﬁcant compared to HIF-1a expression in Rv/d that were transfected with the control-siRNA under hypoxia, ⁄⁄P < 0.01;
signiﬁcant compared to b-catenin expression in Rv/d that were transfected with control-siRNA under normoxia, ⁄⁄⁄P < 0.001).
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with normoxic condition, hypoxic condition promoted b-catenin
nuclear distribution (Fig. 4C), which was consistent with the in-
creased E-cadherin processing under hypoxic condition (Fig. 4B).
To elucidate whether nuclear localized b-catenin is involved in
angiogenesis promoted by d-catenin, we analyzed HIF-1a expres-
sion in the nucleus. Interestingly, consistent with higher b-catenin
nuclear distribution in Rv/d cells, HIF-1a expression in the nucleus
of Rv/d cells was signiﬁcantly higher than that in Rv/C cells under
hypoxic condition (Fig. 4C), indicating higher transcriptional ability
of HIF-1a correlated with higher b-catenin nuclear distribution in
Rv/d cells. Importantly, the knockdown of d-catenin decreased both
nucleus localized b-catenin and HIF-1a protein expression in Rv/d
cells (Fig. 4D), strengthening the possibility that d-catenin regu-
lates b-catenin nucleus localization to mediate HIF-1a transcrip-
tional ability on VEGF induced angiogenesis. This result is in
agreement with our previously report which showed that theknockdown of d-catenin by speciﬁc siRNA blocked E-cadherin pro-
cessing [18]. In order to rule out the possibility that the increased
nuclear accumulation of b-catenin and HIF-1a are just the conse-
quence of the increase on total protein expression, we analyzed
the ratio of nuclear localized proteins to cytoplasmic localized pro-
teins. The data showed that the accumulation is not due to the in-
crease of total level of the proteins (data not shown).
3.4. b-Catenin affected VEGF protein expression and secretion in
CWR22Rv-1 cells but failed to signiﬁcantly affect HIF-1a expression
To conﬁrm the involvement of b-catenin in d-catenin promoted
VEGF production, a speciﬁc siRNA against b-catenin was intro-
duced into Rv/d cells to knock down b-catenin protein expression
(Fig. 5A). Comparing with the control siRNA transfection, in the
Rv/d cells transfected with speciﬁc siRNA, VEGF protein expression
was signiﬁcantly decreased (Fig. 5A). VEGF secretion in the
Fig. 5. The VEGF production was decreased by knockdown of b-catenin while the HIF-1a expression was not signiﬁcantly affected by the knockdown. (A) Speciﬁc b-catenin-
siRNA was introduced into Rv/d cells to knockdown b-catenin protein expression. Control-siRNA did not affect b-catenin expression while the speciﬁc siRNA dramatically
reduced b-catenin expression. The VEGF protein expression in total cell lysate was measured by immunoblot analysis. Cells were harvested after transfecting control-siRNA
and speciﬁc d-catenin-siRNA for 72 h. (B) Rv/d cells transfected with both control-siRNA and speciﬁc b-catenin-siRNA were incubated with serum-free media for 24 h and the
media (50 ll) was collected to perform the VEGF ELISA experiment. (C) The HIF-1a protein expression under normoxia and hypoxia was monitored in Rv/d cells transfected
with both control-siRNA and speciﬁc b-catenin-siRNA.
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HIF-1a protein expression was not signiﬁcantly affected by the
knockdown of b-catenin, indicating that b-catenin plays an impor-
tant role in VEGF production in d-catenin overexpressed cells, but
it did not signiﬁcantly affect HIF-1a protein expression. In other
words, b-catenin itself is not involved in the regulation of the
HIF-1a protein level but in transcriptional activation in
CWR22Rv-1 cells.
4. Discussion
The current study demonstrated that d-catenin can promote
prostate tumor growth by enhancing angiogenesis through in-
creased HIF-1a and VEGF production, which may be mediated by
the wnt/b-catenin signaling pathway.
Pathological angiogenesis, a very important process in tumor
growth occurring through vascular endothelial cells, can be trig-
gered by angiogenic factors such as VEGF. Laura et al. [14] revealed
that d-catenin is overexpressed in vascular endothelium and medi-
ates endothelial cell motility and pathological angiogenesis in a
gene dosage-sensitive manner. Previous reports have discovered
that d-catenin is expressed in prostate tumors and that d-catenin
overexpression promotes prostate cancer cell viability [6,7,17].
Here, we explored a speciﬁc prostate cancer cell line to demon-
strate that d-catenin overexpression could induce angiogenesis in
the CAM assay. In order to elucidate the mechanism underlying
the correlation between d-catenin and angiogenesis, we checked
VEGF production and HIF-1a protein expression. All these data
are evidence of the angiogenic function of d-catenin in
CWR22Rv-1 cells.
Interestingly, in this study, we were able to detect HIF-1a pro-
tein expression under both normoxic and hypoxic conditions by
using speciﬁc HIF-1a antibodies (Santa Cruz biotechnology), and
the density of the protein bands in western blot was found to be
dependent on the sensitivity of the antibodies. However, under
normoxic condition, d-catenin overexpressed cells expressed high-
er HIF-1a level than the control cells (Fig. 3C). HIF-1a is a very un-
ique protein which is stabilized by hypoxic condition and is
degradedmainly by VHL (von Hippel-lindau tumor suppressor) un-
der normoxic condition. Interestingly, in our fractionation experi-
ment, HIF-1a was mainly expressed in the nucleus under
hypoxic condition whereas HIF-1a could only be observed in the
cytoplasm under normoxic condition (Fig.4C and D). This resultindicates that the HIF-1a expression under normoxic condition is
transient and cannot function as a transcription factor. Therefore,
we need to discuss the effect of d-catenin on VEGF production in
normoxic condition.
Zeng et al. [17] found that d-catenin overexpression upregu-
lated cyclin D1 mRNA expression. We previously reported that d-
catenin overexpression increased nuclear distribution of b-catenin
to trigger target gene expression such as cyclin D1, c-jun and c-myc
by promoting E-cadherin processing [18]. In this study, we con-
ﬁrmed and extended that hypoxic condition could aggravate d-
catenin induced E-cadherin processing which, in turn, increased
nuclear distribution of b-catenin. It is well known that b-catenin
binds to TCFs/LEF1 to trigger target genes expression thereby pro-
moting cell growth. Therefore, we believe that the enhanced b-
catenin nuclear distribution in prostate cancer cells overexpressing
d-catenin accelerate cell cycle by binding to TCFs/LEF1 under
normoxic condition. Dilek et al. [20] discovered that b-catenin is
strongly involved in high VEGF expression in pT3 rectosigmoid
cancers. Matono et al. [21] and Watcharasit et al. [22] claimed
the similar observation in sporadic desmoid tumours and neuro-
blastoma SH-SY5Y cells, respectively. Moreover, Easwaran et al.
[23] found seven consensus binding sites for b-catenin/TCF on
the VEGF gene promoter, indicating that b-catenin/TCF can pro-
mote VEGF expression under normoxic condition, which can be
an explanation for our observation of VEGF production under
normoxic condition.
However, under hypoxic condition, we observed that enhanced
HIF-1a nuclear distribution in both Rv/C and Rv/d cells. And in
agreement with other data showed in Figs. 2 and 3, Rv/d cells
showed more distribution of HIF-1a in the nucleus than that in
the Rv/C cells. In our previous study, [24] we found that stability
of d-catenin can be negatively regulated by GSK3b through phos-
phorylation. Flügel et al. [25] reported that HIF-1a can be destabi-
lized by GSK3b in a VHL-independent manner also through the
process of phosphorylation. Therefore, a possible mechanism
explaining more stable expression of HIF-1a in Rv/d cells might in-
volve competitions of d-catenin with HIF-1a to bind to GSK3b, so
that HIF-1a can escape from being degraded by GSK3b phosphor-
ylation and enters the nucleus to function as a transcription factor.
Moreover, this mechanism also could be an explanation for the
interesting observation in current study that knockdown of d-cate-
nin affected the HIF-1a expression (Fig. 3D) whereas knockdown of
b-catenin failed to do the same (Fig. 5C).
Y. He et al. / FEBS Letters 587 (2013) 193–199 199Kaidi et al. [19] revealed that hypoxic condition can inhibit b-
catenin-TCF4 complex formation and transcriptional activity and
interestingly, under hypoxic condition, b-catenin can bind to HIF-
1a to enhance HIF-1-mediated transcription promoting cell
survival and adaption to hypoxia. Based on this discovery and
our current data, we believe that increasing nuclear distribution
of b-catenin is a key step in the angiogenesis induced by d-catenin
overexpression in prostate tumor cells. Under normoxic condition,
overexpressed d-catenin promotes E-cadherin processing to re-
lease b-catenin, which, in turn, enters the nucleus and binds to
TCFs/LEF1 to promote cell growth. Therefore, prostate cells over-
expressing d-catenin grow faster than the control cells and reach
hypoxic condition ﬁrst. Under hypoxic condition, nuclear distrib-
uted b-catenin switches its binding preference from TCFs/LEF1 to
HIF-1a to trigger target genes expression such as VEGF. The secre-
tion of VEGF can induce angiogenesis to provide enough nutrients
and oxygen to make it possible for tumor cell growth without
limitation.
Recently, some scientists reported that d-catenin or its C-termi-
nal fragment is able to enter the nucleus in SH SY5Y human neuro-
blastoma cells [26] or 293T cells [27], respectively. Additionally,
Rodova et al. [28] reported that Kaiso either directly binds or forms
an indirect complex with d-catenin in the nuclei of C2C12 myotu-
bes. These discoveries give rise to a very important possibility that
d-catenin may be a transcription factor that can possibly function
on HIF-1a, which, in turn, triggers VEGF production. Future exper-
iments should explore this possibility to investigate the role of nu-
clear localized d-catenin in prostate cancer cells. Our current study
adds novel evidence regarding the involvement of d-catenin in
prostate cancer and also provides a better understanding about
how d-catenin promotes prostate tumor growth.
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